We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




3D Body Mapping Helps Repair Cellular Damage

By HospiMedica International staff writers
Posted on 02 Jul 2019
Print article
Image: A floating 3D scaffold providing efficient tissue engineering monitoring (Photo courtesy of ACS Nano).
Image: A floating 3D scaffold providing efficient tissue engineering monitoring (Photo courtesy of ACS Nano).
A new study reveals an innovative three-dimensional (3D) instrumented mapping technology that can monitor and track the behavior of engineered cells and tissues.

Developed by researchers at Purdue University (Lafayette, IN, USA) and Hanyang University (Seoul, Republic of Korea), the ultrabuoyant 3D scaffold remains afloat on the surface of a culture medium, providing a favorable environment for the electronic components, which remain in the air while the cells reside and grow underneath. This enables high-fidelity recording of electrical cell–substrate impedance and electrophysiological signals over long periods of time, even weeks. Currently, long-term reliable 3D monitoring is limited by the wet cell culture conditions, which are unfavorable to electronic instrument settings.

The new scaffold, on the other hand, can provide real-time monitoring of the cellular behaviors and functions, thus providing a profound impact on underlying biophysics and disease modeling. A battery of comprehensive in-vitro studies undertaken by the researchers revealed the utility of the platform as an effective tool for drug screening and tissue development following cancer treatments. They are now testing the potential of the device in stem cell therapies and the regenerative treatment of diseases. The study was published in the June 19, 2019, issue of ACS Nano.

“Tissue engineering already provides new hope for hard-to-treat disorders, and our technology brings even more possibilities. My hope is to help millions of people in need,” said senior author biomedical and mechanical engineer Chi Hwan Lee, PhD, of the Purdue College of Engineering. “This device offers an expanded set of potential options to monitor cell and tissue function after surgical transplants in diseased or damaged bodies.”

Tissue engineering, often called regenerative medicine, combines cell cultures, engineering and materials methods, and biochemical and physicochemical factors to improve or replace biological tissues. It involves the use of a tissue scaffold for the formation of new viable tissue for a medical purpose. While it was once categorized as a sub-field of biomaterials, having grown in scope and importance it can be considered as a field in its own.

Related Links:
Purdue University
Hanyang University

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Color Doppler Ultrasound System
KC20

Print article

Channels

Critical Care

view channel
Image: This study is significant as it addresses a treatment approach that has not been extensively studied before (Photo courtesy of 123RF)

Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease

There has been a lack of extensive research on the use of drug-coated balloon (DCB)-only strategy for the treatment of de novo left main coronary artery disease, especially in high bleeding risk (HBR) patients.... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.